Aroa Biosurgery

From Wikitia
Jump to navigation Jump to search
Aroa Biosurgery
Public
Founded2008; 16 years ago (2008)
FounderBrian Ward
Headquarters
Auckland
,
New Zealand
Area served
Worldwide
Key people
Jim McLean (Chairman), Brian Ward (CEO)
ProductsMedical and surgical products
Number of employees
>270
Websitearoa.com

Aroa Biosurgery Limited (Auckland, New Zealand, formerly Mesynthes Limited, New Zealand) is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange (ASX: ARX). The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward (BVSc). The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing (Endoform™ Natural, Endoform™ Antimicrobial and Symphony™) as well as plastics and reconstructive surgery (Myriad Matrix™, Myriad Forme™, Myriad Morcells™, Ovitex® PRS) and repair of hernia (Ovitex® and Myriad Ultra™).

Technology

Aroa Biosurgery develops medical devices using its proprietary ovine forestomach matrix (OFM) technology. OFM is a layer of decellularized extracellular matrix (ECM) biomaterial isolated from the propria submucosa of the rumen of sheep.[1]. OFM is used in tissue engineering and as a tissue scaffold for wound healing and surgical applications.

History

  • 2008 – Mesynthes Limited (Wellington, New Zealand) was founded by Brian Ward[2].
  • 2008 – First patent of ovine forestomach matrix and reinforced biologics[3].
  • 2010 – OFM first described in the scientific literature[4].
  • 2010 – OFM reinforced biologics first described in scientific literature[5].
  • 2011 – Partnership with Hollister Wound Care (Libertyville, IL) to launch and commercialize Endoform Natural™[6].
  • 2012 – Partnership with Tela Bio Inc. to commercialize reinforced biologics[7].
  • 2013 – OFM reinforced biologics (Ovitex®) cleared by US FDA for hernia repair[8].
  • 2014 – Corporate headquarters relocated from Wellington New Zealand to Auckland New Zealand[9].
  • 2015 – Company rebrands to Aroa Biosurgery Limited[10].
  • 2016 – Ovitex® launched in USA in partnership with Tela Bio Inc (Malvern, PA)[11].
  • 2017 – Endoform Antimicrobial™ cleared by the US FDA[12].
  • 2017 – Myriad Matrix™ cleared by the US FDA[13].
  • 2018 – Endoform Antimicrobial™ launched in USA[14].
  • 2018 – Aroa Biosurgery opens first US office (San Diego, California)[15].
  • 2019 – Myriad Matrix™ launched in USA for plastic and reconstructive surgery[16].
  • 2020 – Symphony™ cleared by US FDA[17].
  • 2021 – Myriad Morcells™ cleared by US FDA[18].
  • 2021 – Myriad Morcells™ launched in USA for plastic and reconstructive surgery[19].
  • 2022 – First scientific publication describing novel dead-space management negative pressure system[20]
  • 2023 – Symphony™ launched in USA for advanced wound care.

Awards

  • 2009 – Bayer Innovators Award; awarded by Bayer New Zealand[21]
  • 2011 – Supreme Award, Endoform by Mesynthes; awarded by Wellington Gold Awards[22]
  • 2014 – Fastest Growing Manufacturer; awarded by Deloitte Fast 50[23]
  • 2015 – New Zealand’s Bioscience Company of the Year; awarded by NZBio[24]
  • 2022 – Most Innovative Dressing or Device, Gold Award; awarded by Journal of Wound Care[25]

References

  1. ↑ Lun, S., et al., A functional extracellular matrix biomaterial derived from ovine forestomach. Biomaterials, 2010. 31(16): p. 4517-29.
  2. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  3. ↑ Ward, B.R., K.D. Johnson, and B.C.H. May, Tissue scaffolds derived from forestomach extracellular matrix, USPTO, Editor. 2008, Mesynthes Ltd.: US.
  4. ↑ Lun, S., et al., A functional extracellular matrix biomaterial derived from ovine forestomach. Biomaterials, 2010. 31(16): p. 4517-29.
  5. ↑ Floden, E.W., et al., Biophysical characterization of ovine forestomach extracellular matrix biomaterials. J Biomed Mater Res B Appl Biomater, 2011. 96(1): p. 67-75.
  6. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  7. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  8. ↑ Premarket notification, 510(k) : K130547. 2013; Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K130547.
  9. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  10. ↑ Aroa Biosurgery Poised for Global Growth. 2015 16 March 2023]; Available from: https://www.businesswire.com/news/home/20150622005454/en/Aroa-Biosurgery-Poised-for-Global-Growth
  11. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  12. ↑ Krause, D. Premarket notification, 510(k) : K172318. 2017 13 Mar 2023]; Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf17/K172318.pdf.
  13. ↑ Krause, D. Premarket notification, 510(k) : K153632. 2016; Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf15/K153632.pdf.
  14. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  15. ↑ Aroa Biosurgery appoints new vice-president. 2019 16 March 2023]; Available from: https://www.nbr.co.nz/comings-and-goings/aroa-biosurgery-appoints-new-vice-president/.
  16. ↑ Aroa Initial Public Offering Prospectus. 2020 16 March 2023]; Available from: https://wcsecure.weblink.com.au/pdf/ARX/02257873.pdf.
  17. ↑ Premarket notification, 510(k) : K200413. 2020; Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K200413.
  18. ↑ Liu, L. Premarket notification, 510(k) : K200502. 2021; Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf20/K200502.pdf.
  19. ↑ Aroa Biosurgery Launches New Product, Myriad Morcells™ - Offering Highly Conformable Tissue Regeneration in Wound Beds - Following Recent FDA Clearance. 2021 16 March 2023]; Available from: https://www.businesswire.com/news/home/20210428005356/en/Aroa-Biosurgery-Launches-New-Product-Myriad-Morcells%E2%84%A2---Offering-Highly-Conformable-Tissue-Regeneration-in-Wound-Beds---Following-Recent-FDA-Clearance.
  20. ↑ Mason, I.T.T., et al., Evaluation of Tissue Apposition and Seroma Prevention in an Ovine Model of Surgical Dead Space using a Novel ‘Air-Purged Vacuum Closure’ System. ePlasty, 2022. 2022(22): p. e46.
  21. ↑ Bayer Honours New Zealand’s Leading Innovators. 2009 13 March 2023]; Available from: https://m.scoop.co.nz/stories/BU0908/S00782/bayer-honours-new-zealands-leading-innovators.htm.
  22. ↑ Rutherford, H. Mesynthes supreme winner at Wellington Gold Awards. 2011 13 March 2023]; Available from: https://www.stuff.co.nz/business/5023299/Mesynthes-supreme-winner-at-Wellington-Gold-Awards.
  23. ↑ Listing likely for tissue repair company. 2014 13 March 2023]; Available from: https://www.stuff.co.nz/business/industries/10635849/Listing-likely-for-tissue-repair-company.
  24. ↑ NZ bioscience celebrates its innovators. 2015 24 September 2015 [cited 2023 13 March 2023]; Available from: https://www.scoop.co.nz/stories/SC1509/S00081/nz-bioscience-celebrates-its-innovators.htm.
  25. ↑ Stadler, L. WUWHS – A Hybrid Wound Care Event with a Local Touch in Abu Dhabi. 2022 13 March 2023]; Available from: https://blog.smarttrak.com/wuwhs-a-hybrid-event-with-a-local-touch.

External links

Add External links

This article "Aroa Biosurgery" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.

Retrieved from "https://wikitia.com/index.php?title=Aroa_Biosurgery&oldid=187757"